Clinical Trial Update: Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy and safety of fixed-dose valsartan/hydrochlorothiazide in patients with slight hypertension and target organ damage, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Hypertension
• Ventricular Remodeling

Drugs mentioned

• Diovan HCT (valsartan/hydrochlorothiazide)

Snippet

Sponsor: Federico II University | Conditions: Hypertension, Ventricular Remodeling | Phase 4 | Status: COMPLETED